Please provide your email address to receive an email when new articles are posted on . Mistrust is a key barrier when discussing tumor genomic profiling with African American patients with cancer.

Sikander Ailawadhi, MD, discusses how emerging trends in targeted therapies, immunotherapies, and precision medicine presented at ASH 2024 are addressing unmet needs in the management of hematologic ...

The IGA score, BSA, and DLQI are instruments that Megan Rogge, MD, dermatologist at McGovern Medical School, UTHealth Houston, uses to select and justify treatment options for prior authorization in ...

The most kind of robust method, which tends to be perceived by regulators as the gold standard, is the discrete choice experiment, where you ask patients to choose between two to three “products,” or ...

Delivering high-quality care starts with understanding what matters most to each patient. Clinicians can’t choose treatments that match patients’ priorities and values until they engage with them. The ...

Patient experience and satisfaction assessment has emerged as a cornerstone of healthcare quality evaluation, reflecting both the interpersonal and organisational dimensions of care delivery. Patient ...

Serious illness communications are crucial elements of care delivery for patients with cancer. High-quality serious illness communications are composed of open, honest discussions between patients, ...

Please provide your email address to receive an email when new articles are posted on . Older adults with advanced cancer prioritized quality of life over survival by an 8-to-1 margin. Clinical ...

In Canada, health data are siloed, slowing bioinnovation and evidence generation for personalized cancer care. Secured data-sharing platforms (SDSPs) can enable data analysis across silos through ...

As pharmaceutical R&D policies evolve, the authors argue it is crucial to embed American patient values in reimbursement deliberations and frameworks. Pharmaceutical research and development is a ...